GlassScriptPhysician profile
Christopher J Allphin
NPI 1083841068
$532.59
in general payments reported to CMS, 2019-2025
15 companies · $143 in 2025
The $143 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $67.65 · 2021: $89.89 · 2022: $53.60 · 2023: $98.70 · 2024: $79.64 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $321.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $153.71 | 2023-2025 | Veozah |
| Daiichi Sankyo INC. | $79.72 | 2020-2025 | Injectafer |
| Abbvie INC. | $79.57 | 2020-2025 | |
| Coopersurgical, INC. | $31.79 | 2020-2025 | Paragard T 380a |
| Exeltis, USA INC. | $27.03 | 2022 | |
| Sumitomo Pharma America, INC. | $26.54 | 2025 | Myfembree |
| Aspira Women'S Health INC | $20.46 | 2023 | Ova1 |
| Pfizer INC. | $17.47 | 2021 | |
| Novo Nordisk INC | $16.86 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.09 | 2020 | |
| Shield Therapeutics INC | $15.02 | 2024 | |
| Hologic Sales and Service, LLC | $13.60 | 2021 | |
| Scynexis, INC. | $13.44 | 2022 | |
| Lilly USA, LLC | $11.27 | 2021 | |
| Merck Sharp & Dohme LLC | $11.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Allphin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.